Nutter to host The Capital Network’s Life Science Venture Fast Track 2016Print PDF
Nutter will host The Capital Network’s (TCN) Life Science Venture Fast Track 2016 on February 25. The program is an intensive, interactive full-day seminar designed to provide entrepreneurs, physicians and innovators an in-depth understanding of what it takes to raise early stage capital specifically for life science startups.
Several Nutter attorneys are participating in the program, including:
- Adam Ghander, a partner in the Emerging Companies Group, will present “Startup Story: Wellable,” interviewing Wellable Founder & CEO Nick Patel & Chief Medical Officer Shaan Gandhi on Wellable’s journey from idea to company and what the trajectory of a successful life science startup looks like.
- Michelle Basil, chair of Nutter’s Life Sciences practice group, will present “Money & Metrics: Understanding your Stage and What it Means for Fundraising,” discussing the use of scoring sheets and lean canvas methods to gain a clear picture of what pieces are missing in one’s company structure to maximize one’s fundraising prospects.
- Will Bernat, a partner in the Emerging Companies Group, will present “Negotiations and Term Sheets – an Entrepreneur and Investor Perspective” which will focus on the funding process from start to finish from the perspective of an experienced entrepreneur and his investor.
- Jeremy Halpern, a partner in the Emerging Companies Group as well as a TCN board member, will present “Pitching the Plan” which will focus on how to target, locate, approach, and close with venture capitalists, angels, and strategic investors.
The event also features a mentor lunch where experienced mentors with entrepreneurial and early-stage investing background provide added guidance to attendees.
TCN is a non-profit organization that provides extensive financial education alongside an engaged community to help early-stage entrepreneurs in Boston, and strives to help entrepreneurs master the entire funding process to successfully raise seed capital for their startup.